Latest oppositions filed by Baxalta Gmbh

This table presents recent patent oppositions filed by Baxalta Gmbh against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP2337849Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionSIMIONI, PAOLOMar 12, 2019
EP2634243Improved Process For The Culturing Of CellsDPX HOLDINGS B.V.May 30, 2018
EP2261230Protein Purification MethodCHUGAI SEIYAKU KABUSHIKI KAISHAFeb 12, 2018
EP2634242Improved Process For The Culturing Of CellsDPX HOLDINGS B.V.Dec 21, 2017
EP2634250Improved Process For The Culturing Of CellsDPX HOLDINGS B.V.Dec 21, 2017

The following table provides an overview of the latest patents of Baxalta Gmbh that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3064508Mar 15, 2023Method Of Producing Recombinant High Molecular Weight Vwf In Cell Culture1
EP3521422Oct 6, 2021Substantially Animal Protein-Free Recombinat Furin And Methods For Producing Same1
EP3277718Mar 24, 2021Dosage Regimen For Anti-Mif Antibodies1
EP3121266Apr 22, 2020Oligopeptide-Free Cell Culture Media6
EP2739641Apr 15, 2020Systems And Methods To Increase Protein Yield From Recombinant Manufacturing Processes1
EP3116534May 29, 2019Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders1
EP2652491Nov 29, 2017Eluate Collection Using Conductivity Gradient1
EP2295547Sep 20, 2017Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein Expression1
EP1974014Apr 19, 2017Oligopeptide-Free Cell Culture Media8